Brief: Galderma Receives U.S. FDA Approval For Differin Epiduo Acne Gel Prescription-To-Otc Switch
22/05/2026 17:29
May 22 (Reuters) - GALDERMA GROUP AG GALD.S: RECEIVES U.S. FDA APPROVAL FOR DIFFERIN® EPIDUO® ACNE GEL PRESCRIPTION-TO-OTC SWITCH DIFFERIN EPIDUO TO BE AVAILABLE OTC AT MAJOR RETAILERS BEGINNING SUMMER 2026 Source text: ID:nBwcgYvRSa Further company coverage: GALD.S (Gdansk Newsroom) ((((gdansk.newsroom@thomsonreuters.com ; +48 587785269; ));;))
Recent news on Galderma AG
See all newsBrief: Galderma Receives U.S. FDA Approval For Differin Epiduo Acne Gel Prescription-To-Otc Switch
Bayer down after 'mixed reception' at U.S Supreme Court
Europe Research Roundup: Asta Energy Solutions, Dassault Systemes, Nokia
Swiss stocks - Factors to watch on April 24
Skincare company Galderma posts 25.5% sales leap, driven by US market (updated)